PREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB

Size: px
Start display at page:

Download "PREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB"

Transcription

1 PREP Course 24: Defining the Differences between FDA and OHRP regulations Presented by: Hallie Kassan Dorean Flores Office of the IRB

2 CME Disclosure Statement The North Shore LIJ Health System adheres to the ACCME s new Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by the North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations. Course Director, Kevin Tracey, has disclosed a commercial interest in Setpoint, Inc. as the cofounder, for stock and consulting support. He has resolved his conflicts by identifying a faculty member to conduct content review of this program who has no conflicts. Hallie Kassan and Dorean Flores have nothing to disclose

3 Objectives Define research regulated by FDA vs. that regulated by OHRP Discuss the FDA regulations Discuss OHRP regulations Identify the differences between the two sets of regulations

4 General Considerations Discussion will focus on the main human subjects protection regulations 21 CFR 50 and 56, and 45 CFR 46 Other FDA regulations will not be discussed

5 The Common Rule 45 CFR 46 Regulations overseen by the OHRP within DHHS 21 CFR 50, 56 Regulations overseen by FDA, within DHHS

6 Which Regulations Apply? FDA regulations OHRP regulations clinical investigations human subjects research

7 Clinical Investigation Any experiment that involves a test article and one or more human subjects, and that either must meet the requirements for prior submission to FDA, or results of which are intended to be submitted to or held for inspection by FDA as part of an application for research or marketing

8 Research Systematic investigation designed to contribute to generalizable knowledge

9 Common Rule Human Subject A human subject is a (living) individual about whom an investigator conducting research obtains data through intervention or interaction with the individual or identifiable private information FDA A human subject is an individual who is or becomes a participant in research, either as a recipient of a test article or as a control

10 Which regulations apply when? OHRP FDA OHRP

11 Administrative Differences OHRP - FWA and IRB registration FDA IRB registration Includes number of FDA protocols Types of products reviewed

12 Exemptions The Common Rule Six Exemptions FDA Two Exemptions

13 Common Rule Exemptions 1. Research conducted in established or commonly accepted educational settings, involving normal educational practices 2. Research involving the use of educational tests survey procedures, interview procedures or observation of public behavior, 3. Research involving the use of educational tests, survey procedures, interview procedures, or observation of public behavior that is not exempt under paragraph (b)(2) of this section, if: the human subjects are elected or appointed public officials or candidates for public office; or (ii) federal statute(s) require(s) without exception that the confidentiality of the personally identifiable information will be maintained throughout the research and thereafter.

14 Common Rule Exemptions 4. Research involving the collection or study of existing data, documents, records, or specimens, if these sources are publicly available or if the information is recorded in a deidentified manner 5. Research and demonstration projects which are conducted by or subject to the approval of department or agency heads, and which are designed to study, evaluate, or otherwise examine: (i) Public benefit or service programs; (ii) procedures for obtaining benefits or services under those programs; (iii) possible changes in or alternatives to those programs or procedures; or (iv) possible changes in methods or levels of payment for benefits or services under those programs. 6. Taste and food quality evaluation and consumer acceptance studies,

15 FDA Exemptions Emergency Use of a test article Taste and food quality evaluation and consumer acceptance studies

16 Informed Consent Basic Elements required are the same FDA explicitly requires that consent forms be dated, whereas OHRP does not. FDA (but not OHRP) requires language in the consent form to: 1. Indicate that FDA can inspect records 2. Trial will be listed on clinicaltrials.gov

17 Waivers of Informed Consent Common Rule Allows waivers of informed consent for minimal risk research when proper protections are in place FDA Emergency use of a test article Exception from IC for Emergency Research

18 FDA Exception to Informed Consent Use of specimens in FDA regulated research of IVD

19 Waivers of Documentation of Informed Consent Common Rule Only linking record is ICD and confidentiality breach risk Minimal risk and no procedures requiring consent FDA Minimal risk and no procedures requiring consent

20 Vulnerable Populations Common Rule Special protections for children, pregnant women, fetuses and prisoners Allows for a waiver of parental permission FDA Special protections for children only Does not allow for a waiver of parental permissions

21 Regulatory Actions Common Rule FWA restriction or removal FDA Refusal of Inspection Issuance of Warning Letter Restriction Disqualification of an IRB Any other alternative actions as appropriate

22 What is the same? Definitions of IRB Approval, Minimal Risk, Legally Authorized Representative, IRB Membership Requirements IRB functions and operations IRB review of research Expedited review procedures for minimal risk studies or modifications Criteria for approval of research

23 Questions??

24 Contact the IRB Office of the Institutional Review Board 350 Community Drive Manhasset, NY Phone: Fax:

Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB

Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB Exemption From What??and/or By Whom? Scrutiny by anyone? SBR review?

More information

Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5

Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5 THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 001.2 Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5 Written by: Laura W. Knight,

More information

Human Research Protection Program. Plan

Human Research Protection Program. Plan Human Research Protection Program Plan Revised September 6, 2017 HRP-101 9/6/17 2 of 13 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...

More information

WCG ACADEMY COURSE OVERVIEW

WCG ACADEMY COURSE OVERVIEW WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations

More information

Annual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014

Annual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014 Annual Research Administrators Symposium IRB Compliance Thursday, July 31, 2014 Why IRB Compliance Is Required for Grant Submissions Topics to Cover Today What is an IRB? Why IRB review is required? Regulatory

More information

Advocate Health Care Network. Human Research Protection Program. Plan

Advocate Health Care Network. Human Research Protection Program. Plan Advocate Health Care Network Human Research Protection Program Plan Revised October 19, 2014 Page 1 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Clinical Trial... 3 Engaged in Human Research...

More information

Human Subjects Protection Program Plan

Human Subjects Protection Program Plan December 1, 2016 HRP-101 12/1/16 2 of 12 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research... 3 Human Research:... 4 Human Subject as Defined

More information

Responsible Conduct of Research Providing credible, reliable data (PREP Course #7)

Responsible Conduct of Research Providing credible, reliable data (PREP Course #7) Responsible Conduct of Research Providing credible, reliable data (PREP Course #7) November 15, 2011 350 Community Drive, Goldman Conference Center 9:00-10:30 CME Disclosure The North Shore LIJ Health

More information

Human Research Protection Program Plan

Human Research Protection Program Plan Revised January 19, 2018 Table of Contents Human Research Protection Program Plan HRP-101 1/19/2018 2 of 13 Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...

More information

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Activities that meet the HHS or FDA definition of human subjects research are subject

More information

Human Research Protection Program. Plan

Human Research Protection Program. Plan Human Research Protection Program Plan Dated: September 4, 2014 HRP-101 9/4/2014 2 of 14 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...

More information

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:

More information

What is an IRB (Institutional Review Board)?

What is an IRB (Institutional Review Board)? What is an IRB (Institutional Review Board)? The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National

More information

Rules of Human Experimentation

Rules of Human Experimentation Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office

More information

HUMAN RESEARCH PROTECTION PROGRAM PLAN

HUMAN RESEARCH PROTECTION PROGRAM PLAN HUMAN RESEARCH PROTECTION PROGRAM PLAN HRP 101 June 2017 706-542-3199 irb@uga.edu https://research.uga.edu/hso/ Table of Contents Scope... 2 Purpose... 2 Definitions... 2 Agent... 2 Clinical Trial... 2

More information

Research Involving Human Data or Specimens

Research Involving Human Data or Specimens Page 1 of 5 Research Involving Human Data or Specimens Introduction: The Office for Human Research Protections has issued guidance on research involving coded private information or human biological specimens.

More information

Outline of Discussion

Outline of Discussion This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are

More information

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

EIGHT BASIC ELEMENTS OF INFORMED CONSENT 1/6 This guidance addresses: o Eight Basic elements of informed consent o Additional elements of informed consent o Other information required by the IRB EIGHT BASIC ELEMENTS OF INFORMED CONSENT Required

More information

PREP Workshop # 20: Investigational Drug Accountability. Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS

PREP Workshop # 20: Investigational Drug Accountability. Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS PREP Workshop # 20: Investigational Drug Accountability Presented by: Ji-Eun Kim, Research Pharmacist Investigational Pharmacy Core, CRS CME Disclosure Statement The North Shore LIJ Health System adheres

More information

Human Subjects Protection: Training for Research Teams

Human Subjects Protection: Training for Research Teams Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center

More information

Northwestern University HSPP Policy Manual Page 2 of 116

Northwestern University HSPP Policy Manual Page 2 of 116 Northwestern University HSPP Policy Manual Page 2 of 116 POLICY FOR HUMAN SUBJECTS RESEARCH AT NORTHWESTERN UNIVERSITY 8 I. PREAMBLE: 8 II. OVERVIEW OF THE IRB, OPRS, AND THE HUMAN SUBJECT PROTECTION PROGRAM

More information

Institutional Review Board Compliance Elizabeth City State University

Institutional Review Board Compliance Elizabeth City State University Institutional Review Board Compliance Elizabeth City State University Michelle Moore, MBA Research Compliance Officer/IRB Administrator Office of Sponsored Programs, Contracts & Grants 110 McLendon Hall

More information

Radiation - Florida Department of Health Institutional Review Board

Radiation - Florida Department of Health Institutional Review Board 500-26 Radiation 500-26 Radiation - Florida Department of Health Institutional Review Board Protocol title: Researcher: Application contact: For questions, concerns, to provide input, or request a consultation,

More information

HUMAN SUBJECTS RESEARCH PROTOCOLS

HUMAN SUBJECTS RESEARCH PROTOCOLS HUMAN SUBJECTS RESEARCH PROTOCOLS Guidelines and Application Instructions Institutional Review Board (IRB), Office of Sponsored Programs and Research (OSPR) Determine the Type of IRB Review that is Required

More information

Top Ten Investigator Responsibilities When Conducting Human Subjects Research

Top Ten Investigator Responsibilities When Conducting Human Subjects Research Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility in Medicine & Research) Investigator Responsibility

More information

COOPERATIVE RESEARCH AND EXTERNAL INVESTIGATORS

COOPERATIVE RESEARCH AND EXTERNAL INVESTIGATORS COOPERATIVE RESEARCH AND EXTERNAL INVESTIGATORS Table of Contents I. OHRP Guidance on Engagement of Institutions in Human Subjects Research... 2 II. External Investigators: The institution in question

More information

Trends in Oversight of Human Research Protections?

Trends in Oversight of Human Research Protections? Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for

More information

2013 Metrics on Human Research Protection Program Performance

2013 Metrics on Human Research Protection Program Performance 2013 Metrics on Human Research Protection Program Performance Updated August 1, 2014 About the Metrics Improving the quality of human research protection programs (HRPP) is a top priority of AAHRPP. Effective

More information

Protection of Research Participants: The IRB Process and the Winds of Change

Protection of Research Participants: The IRB Process and the Winds of Change Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick

More information

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout. Wednesday October 10, 2012 Please be sure to sign in and take copies of each handout. 1 Alicia Joy, IRB 2 FH Office of Research Administration Christina Jackson, BSN, RN, CCRC, CHRC 1 ClinicalTrials.gov

More information

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation The Role of the IRB in Clinical Trials: What Patients and Families Need to Know Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation 1 CAC2 Values v Put the children and their families first in

More information

Human Research Protection Program. Investigator Manual

Human Research Protection Program. Investigator Manual Human Research Protection Program Revised July 7, 2014 HRP-910 7/7/2014 2 of 10 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection

More information

Human Research Protection Program Policy

Human Research Protection Program Policy Page 1 of 11 EMERGENCY USE OF AN INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE IN HUMAN SUBJECTS RESEARCH POLICY This policy does not limit the authority of a physician to provide emergency medical

More information

Research Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board

Research Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board Research Data Sharing and Security: The Challenges We Face Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board start us off with your involvement with the IRB and the data security/privacy

More information

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics 11.0 FDA-Regulated Research The IRB evaluates the safety or efficacy of all drugs and devices used in research. Studies involving unapproved or investigational drugs or devices will be reviewed to ensure

More information

CHECKLIST: Pre-review

CHECKLIST: Pre-review 11-5-2014 1 of 5 The purpose of this checklist is to provide support for IRB staff conducting pre-review. This checklist is to be completed by the IRB staff, signed, dated, and retained with the IRB protocol

More information

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

S A I N T M A RY S E M I N A RY O C T O B E R 1 9, IRB BASICS FOR ADMINISTRATORS S A I N T M A RY S E M I N A RY O C T O B E R 1 9, 2 0 1 6 JOHN CARROLL UNIVERSITY Catherine Anson, MA, CRA, CIM Director of Sponsored Research Assistant IRB Chair Carole

More information

Defining research compliance Protocol review committees Conflicts of interest Export Controls

Defining research compliance Protocol review committees Conflicts of interest Export Controls Defining research compliance Protocol review committees Conflicts of interest Export Controls What is Research Compliance? Conformance with Federal, State, and Local Regulations and University Policies

More information

Guidance for IRBs, Clinical Investigators and Sponsors

Guidance for IRBs, Clinical Investigators and Sponsors Guidance for IRBs, Clinical Investigators and Sponsors IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is

More information

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual Cindy Gates IRB Administration What is the purpose of the INVESTIGATOR MANUAL? The manual is designed

More information

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients

More information

Ethical Principles in Clinical Research

Ethical Principles in Clinical Research Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

Collaboration and Efficiency in IRB review of Multi-Site Research

Collaboration and Efficiency in IRB review of Multi-Site Research Collaboration and Efficiency in IRB review of Multi-Site Research Human Subject Research Community Conference University of Miami Student Activities Center (SAC) September 11, 2014 Cynthia Hahn VP, Clinical

More information

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics 11.0 FDA-Regulated Research The IRB evaluates the safety or efficacy of all drugs and devices used in research. Studies involving unapproved or investigational drugs or devices will be reviewed to ensure

More information

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST I. PURPOSE To document the policy and procedures used by the University of Tennessee Graduate School

More information

Human Subjects Research: IRB Resources

Human Subjects Research: IRB Resources Research Compliance Office Human Subjects Research: IRB Resources Kristin B. Frazier HRPP Educational Specialist IRB Resources June 4, 2008 Topics Stanford Institutional Review Boards (IRB) Charge of IRB

More information

Institutional Review Board. Ensuring that the rights and welfare of participants in research are protected.

Institutional Review Board. Ensuring that the rights and welfare of participants in research are protected. Institutional Review Board Ensuring that the rights and welfare of participants in research are protected. Michael Linke, PhD, CIP Presenters Health Science Officer, Veterans Affairs Medical Center Associate

More information

Human Research Participant Protection Program Institutional Review Board (IRB)

Human Research Participant Protection Program Institutional Review Board (IRB) Human Research Participant Protection Program Institutional Review Board (IRB) Procedure 1: Determining whether a research activity needs IRB review and approval 1. Subject All research activities that

More information

Clinical Trials Management for Molecular Diagnostics. April 2016

Clinical Trials Management for Molecular Diagnostics. April 2016 Clinical Trials Management for Molecular Diagnostics April 2016 Clinical Operations Responsibilities Accrue samples that have proper informed consent for use Retrospective cohorts Remnant samples Prospective

More information

Applicability of US Regulations to Canadian Research

Applicability of US Regulations to Canadian Research Applicability of US Regulations to Canadian Research Mary Kate Needler Capital District Health Authority Halifax, Nova Scotia, Canada N2 Stakeholder Meeting August 18, 2014 MK s Conventions: 1. US Regulation

More information

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST

UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST I. PURPOSE To document the policy and procedures used by the University of Tennessee Graduate School

More information

US Special Operations Command Human Research Protection Office

US Special Operations Command Human Research Protection Office S- US Special Operations Command Human Research Protection Office Human Research Protocol Submission Form for Headquarters Level Administrative Review of Extramural* Research PURPOSE: All United States

More information

Research: Ethics, Informed Consent, FDA, Off Label Use

Research: Ethics, Informed Consent, FDA, Off Label Use Research: Ethics, Informed Consent, FDA, Off Label Use Nasim Hedayati, MD, FACS, RPVI Assistant Professor Division of Vascular and Endovascular Surgery University of California, Davis 2015 Phlebology Review

More information

VCU Faculty Held IND and IDE Procedure Handbook

VCU Faculty Held IND and IDE Procedure Handbook VCU Faculty Held IND and IDE Procedure Handbook Contents A. Introduction... 3 B. Purpose of Institutional Oversight... 3 C. Applicability... 4 D. University Oversight of Clinical Investigations Being Conducted

More information

Institutional Review - Protection of Human Subjects

Institutional Review - Protection of Human Subjects The University of Toledo The University of Toledo Digital Repository Higher Learning Commission Office of the Provost Institutional Review - Protection of Human Subjects Research, Office of Follow this

More information

2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS

2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS 2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS 2.1 OBJECTIVE To describe policies and procedures for determining the types of activities that qualifies as human research

More information

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH 1. Overview RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH The ethical and regulatory requirements of The Ohio State University Human Research Protection Program (HRPP) apply to all research

More information

Expedited Review of Human Subject Research

Expedited Review of Human Subject Research Expedited Review of Human Subject Research Table of Contents Eligibility for Expedited Review Expedited Review IRB Oversight of Expedited Review Research Categories Eligible for Expedited Review Review

More information

Title: Review of Medical Devices Page: 1 of 5 Written by:

Title: Review of Medical Devices Page: 1 of 5 Written by: THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 031.1 Title: Review of Medical Devices Page: 1 of 5 Written by: Approved by: Laura W. Knight,

More information

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of

More information

1 The Clinical Research Coordinator (CRC)... 1

1 The Clinical Research Coordinator (CRC)... 1 TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...

More information

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS

Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Basics of Human Subjects Research INSTITUTIONAL REVIEW BOARD OFFICE OF RESEARCH CONTRACTS Presentation Outline What is human subjects research? What are the reasons for IRB review? What is exempt from

More information

2018 Common Rule Implementation Checklist

2018 Common Rule Implementation Checklist 2018 Common Rule Implementation Checklist Action Items The following table outlines certain actions institutions should take or consider taking in light of the 2018 Common Rule s nowdelayed effective and

More information

Protocol Submission Form

Protocol Submission Form Protocol Submission Form 1. Administrative Information Name of Submitting Party: Street: Province/State: Postal/Zip Code: Phone: ( ) E-mail Address: Fax: ( ) Other: ( ) Date: 2. General Study Information

More information

Streamlining IRB Procedures for Expanded Access

Streamlining IRB Procedures for Expanded Access Streamlining IRB Procedures for Expanded Access Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation Richard Klein Director, FDA Patient Liaison Program Office of Health and Constituent Affairs

More information

SWOG Subject: Requests for Patient Data Original Release Date: April 2006 Departments Affected: All Revision Date: May 2013

SWOG  Subject: Requests for Patient Data Original Release Date: April 2006 Departments Affected: All Revision Date: May 2013 SWOG http://swog.org Page 1 of 5 pages Original Release Date: April 2006 Departments Affected: All Revision Date: May 2013 REQUESTS FOR PATIENT DATA FROM SWOG STUDIES 1. Introduction...1 2. Data Sharing...2

More information

Final Rule Material: Secondary Research with Identifiable Information and Biospecimens

Final Rule Material: Secondary Research with Identifiable Information and Biospecimens 2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Final Rule Material: Secondary Research with Identifiable Information and Biospecimens www.citiprogram.org Content

More information

Human Research Protection Program Policy

Human Research Protection Program Policy Adopted: 11/2005 Revised: 03/2014 Page: 1 of 6 RIGHTS AND RESPONSIBILITIES OF PRINCIPAL INVESTIGATORS IN HUMAN SUBJECTS RESEARCH POLICY Each research study will have a Principal Investigator (PI) and may

More information

Good Clinical Practice Compliance

Good Clinical Practice Compliance Good Clinical Practice Compliance Pharmaceutical Regulatory & Compliance Congress Greg Levine LLP Agenda? GCP compliance rules What is the law? What other (non-binding) standards apply? What are the unwritten

More information

Index of Frequently Asked Questions

Index of Frequently Asked Questions Index of Frequently Asked Questions We hope that this frequently asked questions will orient you to basic policies and procedures for IRB review and approval. Feel free to call on us as you navigate the

More information

External IRB Review What Does it Mean for Your Institution

External IRB Review What Does it Mean for Your Institution External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA

More information

Human Research Protections Program Policies and Standard Operating Procedures

Human Research Protections Program Policies and Standard Operating Procedures Human Research Protections Program Policies and Standard Operating Procedures Version Date: April 2018 Presbyterian Healthcare Services Human Research Protections Office and Institutional Review Board

More information

Institutional Review Board

Institutional Review Board Institutional Review Board Policies and Procedures for the Protection of Human Subjects in Research Naval Medical Research Center Research Services Directorate Office of Research Administration Code 025,

More information

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB

June 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB June 15, 2016 Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA five consecutive audits

More information

Tip Sheet 17: Review of Research by the Expedited Procedure

Tip Sheet 17: Review of Research by the Expedited Procedure Tip Sheet 17: Review of Research by the Expedited Procedure Related Accreditation Elements: II.2.E. Policies and procedures should describe review using the expedited procedure, when an expedited procedure

More information

University of Nevada, Las Vegas

University of Nevada, Las Vegas Note: The official name of the Office for the Protection of Research Subjects (OPRS) has been changed to the Office of Research Integrity Human Subjects Research. Any reference to the Office for the Protection

More information

SITE SUBMISSION FORM (SINGLE SITE)

SITE SUBMISSION FORM (SINGLE SITE) *We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed

More information

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network 1.0 Leadership and Decision Making When reading this document, it is important to note that there are several categories

More information

Approaches to Organ Donor Intervention Research Study Design

Approaches to Organ Donor Intervention Research Study Design Approaches to Organ Donor Intervention Research Study Design Barbara E. Bierer, MD Professor of Medicine, Brigham and Women s Hospital and Harvard Medical School Director, Regulatory Foundations, Ethics

More information

IDENTIFYING & MANAGING GCP COMPLIANCE RISKS FOR THE PHARMACEUTICAL, BIOTECH & DEVICE INDUSTRIES

IDENTIFYING & MANAGING GCP COMPLIANCE RISKS FOR THE PHARMACEUTICAL, BIOTECH & DEVICE INDUSTRIES IDENTIFYING & MANAGING GCP COMPLIANCE RISKS FOR THE PHARMACEUTICAL, BIOTECH & DEVICE INDUSTRIES Karen Weaver Epstein, Becker & Green Health Care & Life Sciences Practice APPLICABLE REGULATIONS 21 CFR 312

More information

HCCA: Compliance in Conducting Clinical Research: Conflict of Interest

HCCA: Compliance in Conducting Clinical Research: Conflict of Interest HCCA: Compliance in Conducting Clinical Research: Conflict of Interest Presented by Kendra Dimond, Esq. Epstein, Becker & Green, P.C. Washington, DC 202-861-4186 kdimond@ebglaw.com F. Lisa Murtha, J.D.

More information

Pre-application for KMA Accreditation

Pre-application for KMA Accreditation Pre-application for KMA Accreditation ORGANIZATIONAL INFORMATION Name of Pre-applicant organization: (as it should appear on KMA documents) Chief executive officer of Pre-applicant organization: Name:

More information

International Research Basic Topics to Consider. International Subcommittee Regulatory Foundations, Ethics and Law Program

International Research Basic Topics to Consider. International Subcommittee Regulatory Foundations, Ethics and Law Program International Research Basic Topics to Consider International Subcommittee Regulatory Foundations, Ethics and Law Program Presentation Outline Study Planning, Implementation, and Monitoring Considerations

More information

2 : self-directing freedom and especially moral independence 3 : a self-governing state

2 : self-directing freedom and especially moral independence 3 : a self-governing state A Adverse Effect Adverse Event AE Amendment Approve Approve Pending Assent Assurance Authorization Autonomy Unanticipated problem or unfavorable symptom or disease occurring during a clinical study, though

More information

HCCA Compliance Institute

HCCA Compliance Institute HCCA Compliance Institute Implementing a Clinical Research Compliance Program Kendra Dimond, Partner Epstein Becker & Green Washington, DC 202-861-0900 F. Lisa Murtha, J.D. Chief Audit and Compliance Officer

More information

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah

The Revised Common Rule. Ann Johnson, PhD, MPH IRB Director University of Utah The Revised Common Rule Ann Johnson, PhD, MPH IRB Director University of Utah Objectives Describe the Changes that Affect the UU IRB What does this mean for ERICA? UPDATE: The postponement to January 2019

More information

Good Clinical Practice Handbook

Good Clinical Practice Handbook Division of Microbiology and Infectious Diseases Good Clinical Practice Handbook National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services

More information

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 5.0, February 2, 2009

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 5.0, February 2, 2009 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 DRCR.net is committed to: performing rigorous multi-center clinical

More information

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 6.0, August 2, 2017

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 6.0, August 2, 2017 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 DRCR.net is committed to: performing rigorous multi-center clinical

More information

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network 1.0 Leadership and Decision-Making When reading this document it is important to note that there are several categories

More information

The Revised Common Rule

The Revised Common Rule The Revised Common Rule Where Are We Now? What Happens Next? Heather Pierce, JD, MPH Senior Director, Science Policy Regulatory Counsel hpierce@aamc.org June 20, 2018 2018 AAMC. May not be reproduced without

More information

Institutional Review Board for the Protection of Human Subjects

Institutional Review Board for the Protection of Human Subjects University of Michigan Deep Blue deepblue.lib.umich.edu 2012-10-16 Institutional Review Board for the Protection of Human Subjects Rosenzweig, Merle; Zeylikovich, Irina http://hdl.handle.net/2027.42/94130

More information

IRB HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES INSTITUTIONAL REVIEW BOARD

IRB HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES INSTITUTIONAL REVIEW BOARD IRB INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES REVISED: OCTOBER, Table of Contents Page # INTRODUCTION... 1 CONTACT INFORMATION... 2 PRINCIPLES, ROLES AND

More information

Institutional Review Board. HRP Investigator Manual

Institutional Review Board. HRP Investigator Manual Institutional Review Board HRP 103 - Investigator Manual Revised October 2015 Investigator Manual Page 2 of 50 Contents What is the purpose of this manual?... 4 What is Human Research?... 4 What is the

More information

Stanford University IRB Guidance On Data and Tissue Repositories

Stanford University IRB Guidance On Data and Tissue Repositories Stanford University IRB Guidance On Data and Tissue Repositories Databases, registries (data banks), and repositories (tissue banks) all involve the collection and storage of information and/or biological

More information

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network. Approved August 31, 2015

Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network. Approved August 31, 2015 Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network Approved August 31, 2015 Governance Policies for PCORnet, the National Patient-Centered Clinical Research Network

More information

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH Policy P.11 Written By: B. Laurel Elder Created: June 3, 2013 Edited Replaces 10-9-2009 Version P.11.4 USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH A. Procedure Contents this procedure

More information

BACKGROUND PURPOSE 9/24/2009 DATA AND SAFETY MONITORING

BACKGROUND PURPOSE 9/24/2009 DATA AND SAFETY MONITORING DATA AND SAFETY MONITORING September 2009 Joey Casanova, BBA, CIP Human Subject Research Office SECTION 1 BACKGROUND PURPOSE Data and safety monitoring is the process for reviewing accumulated outcome

More information

ClinicalTrials.gov Registration Guide

ClinicalTrials.gov Registration Guide ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require

More information